{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:08:30Z","timestamp":1793833710187,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bcp.2020.114125","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T13:40:37Z","timestamp":1593178837000},"page":"114125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The development of a targeted and more potent, anti-Inflammatory derivative of colchicine: Implications for gout"],"prefix":"10.1016","volume":"180","author":[{"given":"Guillaume","family":"Par\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Marceau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Vaillancourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bachelard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Naccache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Tuszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2020.114125_b0005","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/01.mjt.0000433937.07244.e1","article-title":"Colchicine: New Insights to an Old Drug","volume":"22","author":"Stack","year":"2015","journal-title":"Am. J. Ther."},{"issue":"26","key":"10.1016\/j.bcp.2020.114125_b0010","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"New England J. Med."},{"key":"10.1016\/j.bcp.2020.114125_b0015","doi-asserted-by":"crossref","unstructured":"A. Slobodnick, B. Shah, S. Krasnokutsky, M.H. Pillinger, Update on colchicine, 2017, Rheumatology (Oxford) 57(suppl_1) (2018) i4-i11.","DOI":"10.1093\/rheumatology\/kex453"},{"issue":"1","key":"10.1016\/j.bcp.2020.114125_b0020","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.bcp.2020.114125_b0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/icb.2009.98","article-title":"Crystal-induced neutrophil activation","volume":"88","author":"Popa-Nita","year":"2010","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114125_b0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine-Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis. Rheum."},{"issue":"8","key":"10.1016\/j.bcp.2020.114125_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081676","article-title":"Modeling the Colchicum autumnale Tubulin and a Comparison of Its Interaction with Colchicine to Human Tubulin","volume":"18","author":"Spasevska","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2020.114125_b0040","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/ar4250","article-title":"Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications","volume":"15","author":"Gagn\u00e9","year":"2013","journal-title":"Arthritis. Res. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2020.114125_b0045","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2381","article-title":"A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients","volume":"10","author":"Syversen","year":"2008","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.bcp.2020.114125_b0050","doi-asserted-by":"crossref","unstructured":"F. Martinon, Mechanisms of uric acid crystal-mediated autoinflammation, Immunol Rev 233(1) 218-32.","DOI":"10.1111\/j.0105-2896.2009.00860.x"},{"issue":"6","key":"10.1016\/j.bcp.2020.114125_b0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/sji.12543","article-title":"Siglec-9 is upregulated in rheumatoid arthritis and suppresses collagen-induced arthritis through reciprocal regulation of Th17-\/Treg-cell differentiation","volume":"85","author":"Wang","year":"2017","journal-title":"Scand. J. Immunol."},{"issue":"11","key":"10.1016\/j.bcp.2020.114125_b0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114125_b0070","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.bcp.2020.114125_b0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00281-013-0361-0","article-title":"Neutrophils, IL-1beta, and gout: is there a link?","volume":"35","author":"Mitroulis","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bcp.2020.114125_b0080","doi-asserted-by":"crossref","unstructured":"J. Torin Huzil, P. Winter, L. Johnson, A.L. Weis, T. Bakos, A. Banerjee, R.F. Luduena, S. Damaraju, J.A. Tuszynski, Computational design and biological testing of highly cytotoxic colchicine ring A modifications, Chemical Biology & drug design 75(6) (2010) 541-50.","DOI":"10.1111\/j.1747-0285.2010.00970.x"},{"issue":"12","key":"10.1016\/j.bcp.2020.114125_b0085","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.joca.2016.07.001","article-title":"Intra-articular basic calcium phosphate and monosodium urate crystals inhibit anti-osteoclastogenic cytokine signalling","volume":"24","author":"Cunningham","year":"2016","journal-title":"Osteoarth. Cartil."},{"issue":"1","key":"10.1016\/j.bcp.2020.114125_b0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10637-015-0315-6","article-title":"Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the betaIII isotype of tubulin","volume":"34","author":"Yeh","year":"2016","journal-title":"Invest. New Drugs"},{"issue":"6979","key":"10.1016\/j.bcp.2020.114125_b0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2020.114125_b0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00236351","article-title":"The mechanism of microtubule associated cytoplasmic transport Isolation and preliminary characterisation of a microtubule transport system","volume":"196","author":"Hyams","year":"1979","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.bcp.2020.114125_b0105","first-page":"97","article-title":"The evolution of cellular movement in eukaryotes: the role of microfilaments and microtubules","volume":"2","author":"Pichichero","year":"1973","journal-title":"Sub-cellular Biochem."},{"key":"10.1016\/j.bcp.2020.114125_b0110","doi-asserted-by":"crossref","unstructured":"L.J. Leandro-Garcia, S. Leskela, I. Landa, C. Montero-Conde, E. Lopez-Jimenez, R. Leton, A. Cascon, M. Robledo, C. Rodriguez-Antona, Tumoral and tissue-specific expression of the major human beta-tubulin isotypes, Cytoskeleton (Hoboken, N.J 67(4) 214-23.","DOI":"10.1002\/cm.20436"},{"issue":"22","key":"10.1016\/j.bcp.2020.114125_b0115","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2174\/1568026617666170104143618","article-title":"Novel Colchicine Derivatives and their Anti-cancer Activity","volume":"17","author":"Johnson","year":"2017","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.bcp.2020.114125_b0120","doi-asserted-by":"crossref","unstructured":"J.T. Huzil, J. Mane, J.A. Tuszynski, Computer assisted design of second-generation colchicine derivatives, Interdisciplinary sciences, computational life sciences 2(2) (2010) 169-74.","DOI":"10.1007\/s12539-010-0076-z"},{"key":"10.1016\/j.bcp.2020.114125_b0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1476-4598-9-131","article-title":"Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives","volume":"9","author":"Tseng","year":"2010","journal-title":"Mol. Canc."},{"key":"10.1016\/j.bcp.2020.114125_b0130","doi-asserted-by":"crossref","unstructured":"J. Torin Huzil, P. Winter, L. Johnson, A.L. Weis, T. Bakos, A. Banerjee, R.F. Luduena, S. Damaraju, J.A. Tuszynski, Computational design and biological testing of highly cytotoxic colchicine ring A modifications, Chemical biology & drug design 75(6) 541-50.","DOI":"10.1111\/j.1747-0285.2010.00970.x"},{"issue":"9","key":"10.1016\/j.bcp.2020.114125_b0135","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1021\/ci800054n","article-title":"Free energy calculations on the binding of colchicine and its derivatives with the alpha\/beta-tubulin isoforms","volume":"48","author":"Mane","year":"2008","journal-title":"J. Chem. Inf. Model"},{"issue":"4","key":"10.1016\/j.bcp.2020.114125_b0140","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1083\/jcb.201406055","article-title":"The tubulin code: molecular components, readout mechanisms, and functions","volume":"206","author":"Janke","year":"2014","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114125_b0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-4682-10-29","article-title":"Determination of the optimal tubulin isotype target as a method for the development of individualized cancer chemotherapy","volume":"10","author":"Ravanbakhsh","year":"2013","journal-title":"Theor. Biol. Med. Model"},{"issue":"18","key":"10.1016\/j.bcp.2020.114125_b0150","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1158\/0008-5472.CAN-11-2861","article-title":"Hematologic beta-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity","volume":"72","author":"Leandro-Garcia","year":"2012","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2020.114125_b0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.1780340311","article-title":"Crystal-Induced Neutrophil Activation. 1. Initiation and Modulation of Calcium Mobilization and Superoxide Production by Microcrystals","volume":"34","author":"Naccache","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2020.114125_b0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20050129","article-title":"CD16b associates with high-density, detergent-resistant membranes in human neutrophils","volume":"393","author":"Fernandes","year":"2006","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bcp.2020.114125_b0165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1189\/jlb.0804479","article-title":"Signaling through CD16b in human neutrophils involves the Tec family of tyrosine kinases","volume":"78","author":"Fernandes","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2020.114125_b0170","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.4049\/jimmunol.176.12.7621","article-title":"Class IA phosphatidylinositide 3-kinases, rather than p110 gamma, regulate formyl-methionyl-leucyl-phenylalanine-stimulated chemotaxis and superoxide production in differentiated neutrophil-like PLB-985 cells","volume":"176","author":"Boulven","year":"2006","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2020.114125_b0175","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/art.11079","article-title":"Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis","volume":"48","author":"Ryckman","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.bcp.2020.114125_b0180","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1189\/jlb.0307174","article-title":"Crystal-induced neutrophil activation. IX. Syk-dependent activation of class Ia phosphatidylinositol 3-kinase","volume":"82","author":"Popa-Nita","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2020.114125_b0185","unstructured":"A. So, A. Dumusc, S. Nasi, The role of IL-1 in gout: from bench to bedside, Rheumatology (Oxford) 57(suppl_1) (2018) i12-i19."},{"issue":"2","key":"10.1016\/j.bcp.2020.114125_b0190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/path.1711340205","article-title":"The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system","volume":"134","author":"Edwards","year":"1981","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114125_b0195","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","article-title":"Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine","volume":"153","author":"Chia","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114125_b0200","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/art.23801","article-title":"Crystal-induced neutrophil activation: X Proinflammatory role of the tyrosine kinase Tec","volume":"58","author":"Popa-Nita","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"14","key":"10.1016\/j.bcp.2020.114125_b0205","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1016\/S0021-9258(18)31582-5","volume":"266","author":"Majumdar","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2020.114125_b0210","doi-asserted-by":"crossref","unstructured":"F. Lagarde, C. Beausoleil, S.M. Belcher, L.P. Belzunces, C. Emond, M. Guerbet, C. Rousselle, Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment, Environmental health : a global access science source 14 (2015) 13.","DOI":"10.1186\/1476-069X-14-13"},{"issue":"3","key":"10.1016\/j.bcp.2020.114125_b0215","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2020.114125_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2017.04.002","article-title":"Towards an understanding of the isotype-specific functions of tubulin in neurons: Technical advances in tubulin expression and purification","volume":"122","author":"Minoura","year":"2017","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.bcp.2020.114125_b0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","article-title":"Prevalence of contraindications and prescription of pharmacologic therapies for gout","volume":"124","author":"Keenan","year":"2011","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.bcp.2020.114125_b0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2165\/11592750-000000000-00000","article-title":"The Challenges of Gout Management in the Elderly:","volume":"28","author":"Stamp","year":"2011","journal-title":"Drugs Aging"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:14:14Z","timestamp":1757769254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220303610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":45,"alternative-id":["S0006295220303610"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114125","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of a targeted and more potent, anti-Inflammatory derivative of colchicine: Implications for gout","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114125"}}